Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogen (NEOG) EBITDA (2016 - 2025)

Neogen (NEOG) has 16 years of EBITDA data on record, last reported at -$5.4 million in Q4 2025.

  • For Q4 2025, EBITDA rose 98.82% year-over-year to -$5.4 million; the TTM value through Nov 2025 reached $195.9 million, up 145.53%, while the annual FY2025 figure was -$237.9 million, 505.54% down from the prior year.
  • EBITDA reached -$5.4 million in Q4 2025 per NEOG's latest filing, up from -$16.1 million in the prior quarter.
  • Across five years, EBITDA topped out at $211.9 million in Q2 2025 and bottomed at -$457.5 million in Q4 2024.
  • Average EBITDA over 5 years is -$5.3 million, with a median of $12.2 million recorded in 2021.
  • Peak YoY movement for EBITDA: crashed 3262.7% in 2024, then soared 1525.08% in 2025.
  • A 5-year view of EBITDA shows it stood at $12.5 million in 2021, then crashed by 161.4% to -$7.7 million in 2022, then soared by 288.94% to $14.5 million in 2023, then plummeted by 3262.7% to -$457.5 million in 2024, then soared by 98.82% to -$5.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA were -$5.4 million in Q4 2025, -$16.1 million in Q3 2025, and $211.9 million in Q2 2025.